News

CPI report, Oracle earnings, Trump’s cash promises and more in Morning Squawk

ORCL, ORCLN, ORCLCL, ORCLUS, ORCL1, ORCL0, ORCLCL0, ORCLCL1, ORCD

Here are five key things investors need to know to start the trading day.

Inovio Nears FDA Decision on INO-3107 as Oct. 30 PDUFA Date Looms

INO

Palantir Bulls Face a Reality Check Before EarningsInovio Pharmaceuticals (NASDAQ:INO) said its biologics license application for INO-3107, an investigational DNA medicine for recurrent respiratory papillomatosis, or RRP, remains under U.S. Food and Drug Administration review, wi

Nonprofit received $2 million from Olivia Rodrigo and Melinda French Gates—it wants to give cash to abuse survivors

The money nonprofit Freefrom received from participating in Olivia Rodrigo's Daisy Chain Music Festival helped the organization hit its annual finacial goal.

Does this AI comic make you laugh?

Comedian Garrett Millerick has created an AI avatar based on his own material. Is it any good?

Can SERV's Revenue Diversification Offset Weaker Uber Deliveries?

SERV, NVDA, SYM

SERV targets $9-$10M in 2026 revenues, as DoorDash growth, advertising and hospital contracts test diversification beyond weaker Uber deliveries.

Do Options Traders Know Something About Netflix Stock We Don't?

NFLX

Investors need to pay close attention to NFLX stock based on the movements in the options market lately.

Implied Volatility Surging for BRT Apartments Stock Options

BRT

Investors need to pay close attention to BRT stock based on the movements in the options market lately.

TLRY Stock Loses 17% in Three Months: Should You Buy, Hold or Sell?

TLRY, CGC, ACB

Tilray's revenues and EBITDA are growing, but weak margins, negative cash flow and competition raise questions about its next move.

US inflation holds steady as diesel prices pass $6 a gallon

Prices in the US rose 3.4% in the 12 months to August, according to the latest official figures.

Macy's Stock Down 5% Despite Q2 Earnings Beat, FY'26 View Raised

M, TGT, KSS, ROST

M's Q2 earnings and sales beat estimates and the company raises its fiscal 2026 outlook, yet shares fall 4.7% as investors weigh a Q3 loss and softer comps.